🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

French Prospective Anterior Cruciate Ligament Reconstruction Cohort Study (FAST)

Recruitingn/aAges 7 Years - anyAllFonds de Dotation pour la Recherche Clinique en O…
NCT02511158 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this study we will examine patients who have undergone anterior cruciate and/or posterior cruciate ligament and/or multi ligaments reconstruction to determine the rate of re-injury, contralateral tear and functional outcomes at least two years after surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * One ligament or multi-ligaments tear of the knee * Surgery reconstruction with any technique Exclusion Criteria: * Patient refusal
💊

What it tests

  • Ligament of the knee reconstruction
📍

Where

1 site
Centre Médico-Chirurgical Paris V (CMCV)
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy